On HealthBeat I have talked about social solidarity as the key to meaningful healthcare reform.

Last night, President-elect Obama sounded that theme repeatedly throughout his victory speech, reminding his audience that he had been elected “by young and old, rich and poor, Democrat and Republican, black, white, Hispanic, Asian, Native American, gay, straight, disabled and not disabled—Americans who sent a message to the world that we have never been just a collection of individuals…”

In the recent past, some progressives have warned that liberals made a mistake when they reached out to minorities, new immigrants, and gays, “ignoring” the mainstream middle class.  But in fact, “mainstream” America is no longer one recognizable culture. It is fast becoming a “magnificent mosaic,” the phrase Mario Cuomo used when he ran to become mayor of New York City in 1977. 

Barack Obama won, not because he managed to win over the white middle-class, or the white working class, but because he managed to put together a coalition from so many groups—including white voters.  Many thanks to Ezra Klein for breaking down the vote: 31.82 percent of voters who chose Obama were white, just as 31.57 percent of the voters who stood for John Kerry in 2004 were white.  But Obama won. What was the difference?

Continue reading →

What is the biggest threat to the U.S. economy?

According to Congressional Budget Office Director Peter Orszag, it is not credit famine, the long-term price of energy, competition from China, the loss of jobs overseas, or even a surfeit of Chrysler SUVs.

It is, Orszag declared in October, “the nation’s looming fiscal gap — which is driven primarily by rising health care costs.”  Healthcare inflation cannot be ignored, Orszag added, because “If we fail to put the nation on a sounder fiscal course. . . we will ultimately reach a point where investors [will] lose confidence and no longer be as willing to purchase Treasury debt at anything but exorbitant interest rates.”

Today, investors outside the U.S. hold $2.74 trillion of Treasuries, or 52 percent of the $5.22 trillion in debt that the U.S. has issued. But now foreign buying of our Treasuries is falling. And, as Orszag has explained elsewhere, if we have to pay “exorbitant interest rates” to persuade foreign investors to  continue buying  our Treasuries, “over time, foreign investors would claim larger and larger shares of the nation’s output and fewer resources would be available for domestic consumption.”  Put simply, our standard of living would fall.

Why does Orszag single out soaring health care costs as the driving force behind our fiscal woes? Because healthcare spending accounts for over 16 percent of GDP, and it continues to grow faster than other sectors, outpacing both growth in GDP and workers’ wages. At $2.3 trillion a year and counting, our national health care bill is rising so fast that it threatens to crowd out other priorities—like spending on education, the environment, and infrastructure repair. Some in the health care industry point out that spending on medicine creates jobs, but as the cost of care levitates, we spend less in other sectors, and jobs in those areas disappear.

Moreover, unlike spending to repair bridges, strengthen schools, or protect the environment, Orszag suggests that the “excess” growth in health care spending is not adding to the wealth—or the health—of the nation. “The gains from higher spending are not clear” the Congressional Budget Office noted recently. “Substantial evidence exists that more expensive care does not always mean higher-quality care.”

Some observers took Orszag’s statement about the importance of health care spending as a signal that he was calling for universal coverage. He was not—not without simultaneously contain costs.

Continue reading →

Be sure to check out the most recent Health Wonk Review, highlighting the best health care

posts of the past two weeks.  David Harlow, of the Health Care Law Blog is the host, and he has done a superb job of rounding up some very interesting posts, including:

Daniel Goldberg’ piece on Medical Humanities Blog explaining the McKeown thesis.  In brief, “McKeown suggests that medicine isn’t necessarily all it’s cracked up to be — 17th-to 20th-century improvements in population health measures likely had more to do with social and economic changes (e.g., improvements in the standard of living) than with public health and medicine (e.g., drugs and shiny objects).”

Joanne Kenen’s interview with, Geisinger CEO Glenn Steele on New Health Dialogue . Geisinger has been

making the “medical home” concept work, and other hospitals and policy experts are trying to figure out how to adapt the model.

Annie, blogging at Home of the Brave, “wondering why nurses and nursing aren’t a bigger part of the discussion on health care reform, given their work in the front lines.”

Louise, of Colorado Health Insurance Insider, who agrees with HealthBeat that advanced medical technology is helping to drive healthcare costs through the roof, but takes issue with my statement that Medicare should be using its clout to negotiate for lower prices. Louise points out that Medicare “has negotiated rates that are far lower than private health insurance reimbursement amounts on many treatments—including dialysis.”  Fair enough—but I’d still like to see Medicare doing what other governments do when it comes to negotiating for discounts with drug-makers, as well as device-makers.

Roy Poses, who castigates Ascension Health for its cut and run maneuver in Detroit at Health Care Renewal, (Ascension closed an inner city hospital while building a new suburban facility).

There are just a few highlights. For the full review, see http://healthblawg.typepad.com/healthblawg/2008/10/health-wonk-review-samhain-edition.html

Over at The Health Care Blog, Douglas Goldstein wrote a post earlier this month on “health eGames,” a category of video games “that deliver measurable health benefits” to patients who play them. iConecto, a developer of such games, recently reported that there are already over 300  health eGames available—and that the size of this market over the next year will be $7 billion+. Consumers definitely seem open to the idea of healthy gaming: Wii Fit, Nintendo’s fitness video game, is poised to become the best selling title of the year, having already sold 8.7 million units.

This got me thinking: what about video games for doctors?

Kevin M.D. began to answer my question on Tuesday when he posted this YouTube clip on his blog:

This video simulates emergency room situations; surgeons can use it to train themselves in particular operations. This is a pretty cool idea: test the skills of a surgeon, but in a context where his slip-ups won’t cost lives.

What’s more surprising is that even conventional video games can play a role in training surgeons. In January, the BBC reported that a British hospital asked “eight trainee surgeons to spend an hour playing [non-medical video games] before performing ‘virtual reality’ surgery” through the program in the YouTube clip above. The hospital found that “game players scored nearly 50% higher on tool control and overall performance than other trainees.” The game that was most effective at improving their skills was Marble Mania, in which the player rolls a marble through a maze and obstacle course.

This isn’t all that weird when you consider how the technical skills you need for most video games—spatial awareness, fast reflexes, dexterity, and precision—are also vital to successful surgery. If a video game can help a surgeon brush up on these skills, it doesn’t matter whether it’s about a marble or a monkey.

Continue reading →

  Hat tip to Kevin M.D. for calling my attention to “The  Covert Rationing Blog,” where  Dr.  Rich offers a concise summary of the dilemma we   face as we move toward a consensus that healthcare is not a privilege,  but something that every human being should have. (One can call that a “right” or a “moral obligation that a  civilized   society has to provide  healthcare to everyone”).   The point Dr.  Rich is making is that once you decide everyone deserves health care, the  question is “how much care.” As he puts it:

  “Exactly how much healthcare are you entitled to  if you have a right to healthcare?  Do you have a right to certain  specified healthcare services, to a certain dollar amount of healthcare per  year or per lifetime, to  whatever healthcare it takes to achieve perfect health, or to some other limit or non-limit?

  “The question of limits (whether we should have  them or not, and what should  they be) has been a central theme of this blog and of DrRich’s book.  To reiterate the fundamental problem: 1) In  America we believe that it is wrong to limit healthcare in any way, that  everyone is entitled to the very best healthcare, that any bit of healthcare  that offers even a small potential of benefit should be provided, and that  death itself is merely a manifestation of insufficient research (or actionable incompetence,  or systematic  discrimination against the unwealthy, or corporate greed).  2) But  against that closely held belief, we must balance the unremitting law of  economics which tells us that there is simply not enough money in the known  universe to buy all the healthcare that might potentially offer some small  amount of benefit to every person.  Healthcare spending has to be limited,  or it will become a fiscal  black hole.”

Continue reading →

On November 3rd the Supreme Court will hear the case of Wyeth v. Levine, which has been called the “business case of the century”—and with good reason. In essence, Monday’s ruling will decide if patients have the right to sue pharmaceutical companies for personal injuries stemming from prescription drugs approved by the Food and Drug Administration (FDA). This is the big one, folks.

First, the details of the case: In the spring of 2000, Diana Levine of Vermont received treatment for migraines which consisted of the painkiller Demerol and Phenergan, an antihistamine manufactured by Wyeth Pharmaceuticals. Phenergan is typically injected directly into the muscle or dripped into the vein through steady doses (a procedure called an “IV drip”). When administering the drug, clinicians must be careful not to expose it to blood in the arteries; doing so causes “swift and irreversible gangrene,” to use an evocative phrase from a September New York Times article on Levine’s case.

Unfortunately, the physician assistant who attended to Levine administered Phenergan neither through muscular injection nor IV drip, but through a process called “IV push”—a direct intravenous shot in the arm. The assistant missed and hit an artery. Over the next few weeks, Levine, who was an avid guitarist, saw her right hand and forearm turn purple and then black—until both were finally amputated.

The court battle is over whether or not Wyeth Pharmaceuticals sufficiently warned against the dangers of IV push on its packaging for Phenergan—packaging that had been approved by the FDA. The drug’s labeling did warn that it was preferable to give Phenergan through IV drip, and warned that “inadvertent intra-arterial injection”—accidentally injecting the drug into an artery—could cause “gangrene requiring amputation.” But nowhere on the Phenergan label was there an express warning that the method of IV push is extremely risky for this very reason.   

Continue reading →

No doubt you’ve seen the ads. Barack Obama claims that John McCain plans to hollow out Medicare, arguably the most popular social program in America.

McCain says that just isn’t so.

The controversy began early this month when the Wall Street Journal reported that McCain plans major reductions in Medicare and Medicaid spending totaling $1.3 trillion over the text ten years. This will help pay for his health care plan. Douglas Holtz-Eakin, McCain’s senior policy adviser, told the Journal that “the savings would come from eliminating Medicare fraud and by reforming payment policies to lower the overall cost of care.”

Without question, there is money to be saved if Washington cracks down on Medicare and Medicaid fraud. But before reaping any savings, the government first would have to spend money to ferret out the fraudulent claims. And no one believes that Washington could recover anything close to $1.3 trillion. Meanwhile, “reforming payment policies” seems to suggest that McCain plans to pay doctors and hospitals less, at a time when many Medicare patients are having a hard time finding a primary care physicians—precisely because Medicare’s fees are already so low. This could reduce access to care.

Barack Obama quickly went on the attack with ads warning that McCain would take “Eight hundred and eighty-two billion from Medicare alone…requiring cuts in benefits, eligibility, or both.”

Continue reading →

At the end of last week, the Wall Street Journal published an editorial designed to terrify anyone who is afraid that a “single-payer” health care system would signal the end of democracy in America. The country is about to be taken over by the “left-wing,” the editorial warned, the same wild-eyed radicals who brought us the 1960s.  And what lies at the center of their master-plan? Medicare-for-all.

Since the piece relies so heavily on half-truths and innuendo—particularly with regard to healthcare—I feel obliged to comment.

The editorial, which is titled “A Liberal Supermajority,” begins by declaring that the election is a done deal: “if current polls hold, Barack Obama will win the White House on November 4 and Democrats will consolidate their Congressional majorities, probably with a filibuster-proof Senate or very close to it. Without the ability to filibuster, the Senate would become like the House, able to pass whatever the majority wants.”

“If current polls hold .  . .”   And, “if current polls” are accurate…

I have lived through enough presidential elections to know that the American electorate cannot be second-guessed.  Particularly in an election like this one, when highly charged issues such as loyalty to the nation, religion and race become part of the mix, one cannot assume that what a voter is willing to tell a stranger is necessarily the truth about how she will cast her ballot.

Continue reading →

Sometimes I agree with New York Times’ editorials. Sometimes I don’t. But I rarely learn much from them. To my mind, the problem with the form is that it encourages opining without evidence. So, I admit, I rarely turn to the editorials. .

But yesterday Buckeye Surgeon pricked my curiosity by referring to a recent New York Times editorial as a “masterpiece of naiveté and contempt.”

Such strong language suggested that the editorial might be entertaining. Thus, I went back and read what turned out to be a piece congratulating Medicare for having decided it “will no longer pay hospitals for the added cost of treating patients who acquire any of 10 ‘reasonably preventable’ conditions while hospitalized. Those include incompatible blood transfusions, severe bedsores, injuries from falls, poor blood sugar control, and infections after certain surgeries.”

This is what I mean about editorials: typically they are monologues that cry out for a good copy editor who asks sensible, logical questions.  The first query that springs to mind is this:  exactly what does “preventable” mean?  How is a “fall” preventable?

If Mr. Smith decides to get out of bed, begins shuffling toward the hallway, feels woozy, loses his balance and falls, how could the fall have been avoided?  Should a member of the staff be stationed not more than six feet from each patient, ready to race in and catch him if he teeters? Or should Mr. Smith have been tied to his bed?  (Thanks to HealthBeat reader Howard B. for his comment on hospital falls about a year ago.)

Continue reading →

This post was written by Niko Karvounis & Maggie Mahar

Consider this headline: “Health insurers reinvent themselves as money managers.”

The short version of the story, which appeared in the Los Angeles Times yesterday, is this:  “insurers are moving away from their traditional role of pooling health risks [and paying for health benefits]” and, instead, are beginning to move into money management as they offer to help consumers save for and pay for their own healthcare. If this strikes you as troubling—if, in other words, you think that health insurance should be about health care and not banking—then a closer look at  Michael Hiltzik’s well-researched piece will make your stomach churn. (Thanks to a Health Beat reader for calling our attention to what he called a “chilling” story.)

Health Beat has written about the health savings accounts (HSAs) that encourage consumers to sock away money away to pay for their own medical expenses in the past. To re-cap briefly: An HSA is like a 401k—you do not pay taxes on the dollars you put into the plan. There’s just one requirement: you can open a HSA only if you also buy a high-deductible insurance plan that typically offers minimal coverage, and a deductible of, say, $5,000. 

Because the premiums of high-deductible plans are so much lower than other health insurance products, they can be attractive to many low-income Americans—even if they do not have the extra cash to put away in an HSA (Remember: if you want an HSA, you must buy a high-deductible plan; but if you buy a high-deductible plan, you are not required to open a HSA.).

High-deductible plans are gaining traction in our health care system: America’s Health Insurance Plans report that, at the start of this year, 6.1 million Americans were covered by high-deductible plans—up from 3.2 million in 2006.

Why such fast growth? One big reason is that powerful health care stakeholders—namely, employers and health insurance companies—see the plans as a way to cut costs by shifting costs to the consumer.  As the Times points out, high-deductible plans offer “fewer overall benefits than traditional plans. They are designed to cover chiefly catastrophic medical expenses. Routine medical care becomes the responsibility of the consumer. Some of the plans exclude maternity benefits, preventive care and mental health services.”

Continue reading →